What Is Stem Cell Therapy and How Does It Work? A Physician's Plain-English Guide

What Is Stem Cell Therapy, Exactly?

If you've spent any time researching options for chronic pain, joint damage, or a slow-healing injury, you've probably come across stem cell therapy — often marketed as a way to "regenerate" damaged tissue without surgery. But the term gets used loosely, and the marketing rarely matches the science. At The Bridge Health Recovery Center, our guests ask us about it often, so let's start with a plain-English definition.

Stem cells are the body's raw materials — cells with the potential to develop into many different specialized cell types (muscle, cartilage, bone, nerve, and more) and to divide and renew themselves. In regenerative medicine, the idea is to introduce concentrated stem cells into an area of damage or dysfunction, where they may help modulate inflammation and support the body's own repair processes.

That's an important distinction: current research suggests stem cells used this way primarily act as signaling and modulating agents — helping recruit the body's own healing response — rather than literally growing brand-new tissue on demand. Some patients and clinics describe far more dramatic claims, and that's exactly where things go wrong.

"The honest answer is: we don't fully know yet how much stem cell therapy helps for most chronic pain conditions. What we do know is that it's not a magic reset button — and anyone who tells you otherwise isn't giving you the full picture." — Dr. Daren Brooks, D.O.

How Stem Cell Therapy Works in the Body

In a typical procedure, stem cells are harvested from the patient (autologous) or from a donor source such as umbilical cord tissue (allogeneic), concentrated in a lab or point-of-care device, and then injected or infused into the target area — a joint, the spine, or intravenously for systemic effect.

Once introduced, the theory is that stem cells:

• Travel to areas of injury or inflammation, guided by chemical signals released by damaged tissue
• Release growth factors and signaling molecules that may reduce local inflammation
• Support the recruitment and activity of the body's own repair cells
• In some laboratory and animal models, differentiate into replacement tissue cells

Human clinical evidence for that last mechanism — actual differentiation into new, functional tissue after injection — remains limited for most orthopedic and pain applications. Most of the observed clinical benefit researchers currently attribute to the anti-inflammatory and modulating effects, not tissue regrowth. This is a rapidly evolving research area, and legitimate scientists are honest that the full mechanism, and its real-world magnitude of benefit, is still being studied.

Types of Stem Cells Used in Treatment

Not all "stem cell therapy" is the same. The source and preparation method matter a great deal:

• Bone marrow-derived (BM-MSCs): Harvested from the patient's own hip bone, concentrated, and re-injected. One of the more studied autologous sources for orthopedic use.
• Adipose-derived (fat-derived): Collected via a mini-liposuction procedure, processed to isolate stem cells, then injected. Popular in cosmetic and orthopedic clinics.
• Umbilical cord / Wharton's jelly-derived: Donor-derived, marketed as "younger" and more potent cells. Regulatory scrutiny here has increased significantly, as some products sold this way have not been properly screened or manufactured.
• Amniotic fluid/tissue products: Often marketed as containing live stem cells, though FDA testing has found some commercial amniotic products contain few or no viable stem cells at all.

What's FDA-Approved vs. Investigational

This is the single most important section of this article, because it's where most marketing misleads patients.

The FDA has approved certain stem cell-based products — but almost exclusively hematopoietic (blood-forming) stem cells derived from bone marrow, peripheral blood, or umbilical cord blood, used to treat specific blood and immune system disorders like certain leukemias and lymphomas. That is a narrow, well-defined category.

For the uses most commonly marketed to chronic pain, orthopedic, and cosmetic patients — knee osteoarthritis, back pain, joint injuries, anti-aging, general "regeneration" — these treatments are, with rare exceptions inside approved clinical trials, investigational and not FDA-approved. That doesn't automatically mean they're ineffective or unsafe, but it does mean:

• The FDA has not reviewed evidence showing they are safe and effective for that specific use
• Manufacturing and quality standards may not be independently verified
• Insurance will typically not cover the treatment
• Outcomes and risks are less predictable than for approved therapies

The FDA has published multiple public safety communications and warning letters about clinics offering unapproved stem cell products, including reports of patients experiencing infections, tumors, and blindness after unregulated injections. This isn't a reason to dismiss regenerative medicine outright — the research is genuinely promising in places — but it is a reason to approach any specific clinic's claims with informed skepticism.

Conditions People Explore Stem Cell Therapy For

Patients and clinics discuss stem cell and related regenerative approaches for a wide range of conditions, including:

• Knee, hip, and shoulder osteoarthritis
• Degenerative disc disease and chronic back pain
• Tendon and ligament injuries (rotator cuff, Achilles, ACL)
• Post-surgical recovery and slow-healing wounds
• Chronic pain conditions with an inflammatory component

Emerging research, particularly in orthopedic applications like knee osteoarthritis, suggests some patients report reduced pain and improved function following certain stem cell or PRP protocols — but study quality varies widely, placebo response in injection studies is notoriously high, and long-term data is still limited. Reputable researchers describe the evidence as "promising but not yet definitive," which is a very different message than "proven cure" — a phrase you should never trust from any provider.

What to Expect During Treatment

If you and a physician decide to explore a legitimate, well-supervised regenerative procedure, the general process typically looks like this:

1. Comprehensive evaluation: Full medical history, imaging, and a discussion of your goals and realistic expected outcomes.
2. Cell collection: A minor procedure to draw bone marrow or fat tissue (for autologous treatments), or preparation of a donor-derived product.
3. Processing: Concentration of the cell sample, ideally with documented quality testing.
4. Injection or infusion: Delivered to the target joint, tissue, or intravenously, sometimes with imaging guidance for accuracy.
5. Recovery and follow-up: Rest guidelines, activity modification, and scheduled follow-up to track outcomes objectively — not just anecdotally.

A responsible provider will also document your outcomes over time and be transparent if the treatment isn't working, rather than recommending repeated rounds without evidence of benefit.

Risks, Limitations, and Realistic Expectations

Every medical procedure carries risk, and stem cell therapy is no exception. Documented risks include infection at the injection or harvest site, pain or swelling, and — in rare but serious cases reported to the FDA — tumor formation and other serious complications, particularly with poorly regulated or improperly sourced products.

Beyond physical risk, there's a financial and emotional risk: patients spending significant out-of-pocket money on a treatment with uncertain benefit, sometimes delaying evidence-based care in the process. Setting realistic expectations matters:

How to Spot an Unproven or Predatory Clinic

Because this space is loosely regulated, learning to spot warning signs protects both your health and your finances. Be cautious of any clinic that:

• Promises cures, guarantees, or specific success percentages
• Treats nearly every condition with the same product or injection
• Won't clearly answer whether their product is FDA-approved for your condition
• Pressures same-day payment or discourages you from seeking a second opinion
• Has no licensed physician actually reviewing your case, or relies heavily on non-medical sales staff
• Lacks any published research, registered clinical trial, or transparent outcomes tracking

The FDA maintains public communications naming specific clinics under enforcement action — it's worth a search before committing to any provider. When in doubt, get a second, independent medical opinion from a physician with no financial stake in the treatment.

"I tell patients the same thing I'd want a doctor to tell someone I love: ask who's regulating this, what happens if it doesn't work, and what your alternatives are — before you spend a dollar." — Dr. Daren Brooks, D.O.

This article is educational and not medical advice. Regenerative medicine research is evolving quickly; always consult a licensed physician who can evaluate your specific medical history before pursuing any treatment.

If chronic pain is the reason you're researching stem cell therapy, it's worth knowing that understanding how chronic pain works in the brain and nervous system often opens up effective, evidence-based paths to relief that don't carry the cost or uncertainty of investigational procedures. Many guests at The Bridge come to us after exploring options like this one, looking for chronic pain management without opioids that actually addresses the root nervous system dysregulation driving their pain — including those managing complex regional pain syndrome (CRPS).

Frequently Asked Questions